Table 1 Patient characteristics
Variable | µ (95%CI)/n (%) | |
|---|---|---|
Age (years) | 62.2 (61.5; 62.9) | |
PSA (ng/mL) | 7.2 (6.8; 7.6) | |
Lymph node invasion | 18 (5.8) | |
Clinical tumor stage | 1 | 257 (83.2) |
2 | 52 (16.8) | |
Preoperative Gleason score | 3 + 3 | 11 (3.6) |
3 + 4 | 161 (52.1) | |
4 + 3 | 137 (44.3) | |
Postoperative Gleason score | 3 + 3 | 13 (4.2) |
3 + 4 | 70 (22.7) | |
4 + 3 | 157 (50.1) | |
4 + 4 | 25 (8.1) | |
4 + 5 | 10 (3.2) | |
Positive core biopsies (n = 309) | 4.3 (3.9; 4.6) | |
Negative core biopsies (n = 309) | 6.8 (6.3; 7.3) | |
Pathologic tumor stage | 2 | 210 (68.0) |
3 | 96 (31.1) | |
Number of dissected lymph nodes | 14.8 (14.3; 15.3) | |
Surgical margin tumor positive | 102 (33.0) | |
Clavien-Dindo complication grade | ≤ 2 | 221 (71.5) |
3 | 83 (26.9) | |
4 | 4 (1.3) | |
5 | 1 (0.3) |